Vascular Complications of Q-fever Infections, European Journal of Vascular and Endovascular Surgery, vol.42, issue.3, pp.384-92, 2011. ,
DOI : 10.1016/j.ejvs.2011.04.013
Long-term outcome of Q fever endocarditis: a 26-year personal survey, The Lancet Infectious Diseases, vol.10, issue.8, pp.527-562, 2010. ,
DOI : 10.1016/S1473-3099(10)70135-3
Vascular complications and surgical interventions after world's largest Q fever outbreak, Journal of Vascular Surgery, vol.62, issue.5, pp.1273-80, 2015. ,
DOI : 10.1016/j.jvs.2015.06.217
Chronic Q fever: Review of the literature and a proposal of new diagnostic criteria, Journal of Infection, vol.64, issue.3, pp.247-59, 2012. ,
DOI : 10.1016/j.jinf.2011.12.014
Relevance of the positron emission tomography in the diagnosis of vascular graft infection with Coxiella burnetii, Comparative Immunology, Microbiology and Infectious Diseases, vol.35, issue.1, pp.45-54, 2012. ,
DOI : 10.1016/j.cimid.2011.09.010
Localizing chronic Q fever: a challenging query, BMC Infectious Diseases, vol.51, issue.8, p.413, 2013. ,
DOI : 10.2967/jnumed.109.072371
ABSTRACT, Clinical and Vaccine Immunology, vol.19, issue.5, pp.787-90, 2012. ,
DOI : 10.1128/CVI.05724-11
Serology in chronic Q fever is still surrounded by question marks, European Journal of Clinical Microbiology & Infectious Diseases, vol.40, issue.Suppl 2, pp.1089-94, 2014. ,
DOI : 10.1128/JCM.40.9.3526-3529.2002
Genetic Variation in Pattern Recognition Receptors and Adaptor Proteins Associated With Development of Chronic Q Fever, Journal of Infectious Diseases, vol.64, issue.5, pp.818-847, 2015. ,
DOI : 10.1128/IAI.68.10.5673-5678.2000
by NOD2 Is Central for the Induction of an Inflammatory Reaction, The Journal of Infectious Diseases, vol.201, issue.12, pp.1849-58, 2010. ,
DOI : 10.1086/652871
Coxiella burnetii, the Agent of Q Fever, Replicates within Trophoblasts and Induces a Unique Transcriptional Response, PLoS ONE, vol.69, issue.12, p.15315, 2010. ,
DOI : 10.1371/journal.pone.0015315.s004
URL : https://hal.archives-ouvertes.fr/hal-00611145
Specific Interferon ?? Detection for the Diagnosis of Previous Q Fever, Clinical Infectious Diseases, vol.52, issue.12, pp.1742-51, 2013. ,
DOI : 10.1093/cid/cir132
CXCR3 ligands in disease and therapy, Cytokine & Growth Factor Reviews, vol.26, issue.3, pp.311-338, 2015. ,
DOI : 10.1016/j.cytogfr.2014.11.009
CXCR3 ligands: redundant, collaborative and antagonistic functions, Immunology and Cell Biology, vol.8, issue.2, pp.207-222, 2011. ,
DOI : 10.1158/1535-7163.MCT-08-0485
URL : http://www.nature.com/icb/journal/v89/n2/pdf/icb2010158a.pdf
Chemokine Monokine Induced by IFN-??/CXC Chemokine Ligand 9 Stimulates T Lymphocyte Proliferation and Effector Cytokine Production, The Journal of Immunology, vol.172, issue.12, pp.7417-7441, 2004. ,
DOI : 10.4049/jimmunol.172.12.7417
URL : http://www.jimmunol.org/content/jimmunol/172/12/7417.full.pdf
Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase, Biochemical and Biophysical Research Communications, vol.310, issue.3, pp.889-96, 2003. ,
DOI : 10.1016/j.bbrc.2003.09.098
Beyond the IFN-?? horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis, European Respiratory Journal, vol.43, issue.5, pp.1472-86, 2014. ,
DOI : 10.1183/09031936.00151413
Discriminating between latent and active tuberculosis with multiple biomarker responses, Tuberculosis, vol.91, issue.3, pp.250-256, 2011. ,
DOI : 10.1016/j.tube.2011.02.006
URL : http://europepmc.org/articles/pmc3090479?pdf=render
Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis, The International Journal of Tuberculosis and Lung Disease, vol.19, issue.12, pp.1476-84, 2015. ,
DOI : 10.5588/ijtld.15.0325
Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice, Diagnostic Microbiology and Infectious Disease, vol.81, issue.4, 2014. ,
DOI : 10.1016/j.diagmicrobio.2014.12.008
Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children, BioMed Research International, vol.13, issue.11, p.589471, 2015. ,
DOI : 10.1371/journal.pone.0121021
A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study, The Lancet Infectious Diseases, vol.17, issue.4, 2016. ,
DOI : 10.1016/S1473-3099(16)30519-9
A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever, Clinical Microbiology and Infection, vol.20, issue.7, pp.642-50, 2014. ,
DOI : 10.1111/1469-0691.12423
Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal Experiments to a Population-Based Pilot Study, PLOS ONE, vol.105, issue.Suppl 1, p.141394, 2015. ,
DOI : 10.1371/journal.pone.0141394.s004
CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study, Journal of Cardiovascular Translational Research, vol.51, issue.5, pp.302-316, 2016. ,
DOI : 10.3109/10408363.2014.913549
Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in the Netherlands, Transfusion, vol.48, issue.1, pp.144-50, 2012. ,
DOI : 10.1128/JCM.01006-10
T Cells Are Essential for Bacterial Clearance, and Gamma Interferon, Tumor Necrosis Factor Alpha, and B Cells Are Crucial for Disease Development in Coxiella burnetii Infection in Mice, Infection and Immunity, vol.75, issue.7, pp.3245-55, 2007. ,
DOI : 10.1128/IAI.01767-06
Role of CD4+ and CD8+ T Cells in Clearance of Primary Pulmonary Infection with Coxiella burnetii, Infection and Immunity, vol.78, issue.7, pp.3019-3045, 2010. ,
DOI : 10.1128/IAI.00101-10
Markers of infection in inpatients and outpatients with acute Q-fever, Clinical Chemistry and Laboratory Medicine, vol.13, issue.11, pp.1407-1416, 2009. ,
DOI : 10.1128/IAI.71.7.3714-3723.2003
Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands1, Emerging Infectious Diseases, vol.21, issue.8, pp.1348-56, 2015. ,
DOI : 10.3201/eid2108.140196